Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd. experienced notable stock activity, reaching an intraday high and outperforming the China Shanghai Composite index for the day. The company has shown resilience year-to-date and over the past year, with solid returns and a market capitalization of CNY 11,262 million.

Zhejiang Hisun Pharmaceutical Co., Ltd. has seen a significant rise in stock performance, reaching an intraday high and reflecting positive market sentiment. Over the past year, the company has outperformed the broader market index, despite recent short-term challenges. It maintains a strong financial position within the pharmaceuticals sector.

Zhejiang Hisun Pharmaceutical Co., Ltd. saw a notable decline in its stock price, contrasting with the broader market's performance. Over the past week and month, the stock has decreased significantly, while year-to-date figures show a slight drop. The company maintains a market capitalization of CNY 11,262 million and a price-to-earnings ratio of 25.00.

Zhejiang Hisun Pharmaceutical Co., Ltd. has shown strong performance recently, with a year-to-date increase of 4.85% and a one-year return of 21.71%. The company, with a market capitalization of CNY 11,262 million, maintains a price-to-earnings ratio of 25.00 and a dividend yield of 2.25%.